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A 33year-old man was admitted to the medical ward at Queen 
Elizabeth Central Hospital for evaluation of  a pleural effusion 
that had progressed despite anti-bacterial and tuberculosis 
treatment. Eight months earlier he was diagnosed with 
sputum smear alcohol and acid-fast bacilli [AAFB] negative 
pulmonary tuberculosis. At that time his symptoms were fever, 
night sweats, cough and shortness of  breath. The results of  
his initial chest X-ray are not known. He received standard 
tuberculosis treatment (rifampicin, isoniazid, pyrazinamide 
and ethambutol for 2 months followed by rifampicin and 
isoniazid for four months). He stated that his symptoms 
improved during the first two months of  tuberculosis 
treatment,but he then developed a pleural effusion that 
was tapped three times over the course of  the four months 
prior to admission. Straw colored fluid was obtained twice 
but results of  microbiological and biochemical analysis of  
the pleural fluid samples were not available.The last time a 
dry pleural tap was recorded. Courses of  amoxicillin and 
chloramphenicol were given without improvement. Five 
days before admission he developed progressive complaints 
of  productive cough with brownish sputum and shortness 
of  breath on exertion. He had no constitutional symptoms. 
He was a lifetime non-smoker and had no exposure to 
asbestos or significant amounts of  particulate matter. He 
was HIV positive with World Health Organization (WHO) 
clinical stage 3 disease (pulmonary TB) and a CD4 count 
of  187cell/μL. He had started antiretroviral therapy with 
stavudinelamivudine- nevirapine 14 weeks before admission 
along with cotrimoxazole prophylaxis.
On examination he was well nourished and not in respiratory 
distress. Discrete, firm, non-tender lymph nodes, 1-2cm in 
diameter were found in the sub-mandibular area. His blood 
pressure was 120/80 mmHg, pulse rate 100/min, respiratory 
rate 26/min and temperature 37.5oC. The trachea was 
deviated to the right side. He had reduced chest expansion, 
stony dull percussion and reduced breath sounds as well as 
a few crepitations on the right side of  the chest. The rest 
of  the examination was normal. In particular, there were 
no signs of  heart failure, ascites or Kaposi’s sarcoma. Full 
blood count results were as follows: WBC = 9,300/μL (with 
normal differential count), Hb = 11.7 g/dL and platelet 
count of  346,000/μL. A chest X-ray (figure 1) taken shortly 
after admission, showed opacification of  most of  the right 
lung with mild apical sparing, suggestive of  massive pleural 
effusion or extensive dense consolidation. The volume of  the 
right hemithorax appeared to be reduced. A CT scan of  the 
chest (figure 2) was made which was reported as follows: Right 
pleural fluid collection of  8 by 3cm with concentric pleural 
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thickening in the upper right chest. Infiltrates throughout 
the right lung with basal bronchiectasis. No discrete mass 
was noted. A diagnostic pleural aspiration obtained pus-like 
fluid; the white blood cell count was 263,000/mm3 with 10% 
neutrophils and 90 % lymphocytes. The protein content was 
12.1g/dL and no AAFB’s or bacteria were seen on Ziehl-
Neelsen and gram stain respectively.
1. What is your differential diagnosis?
2. Which additional investigations would you plan?
Figure 1. Chest X-ray on admission
Figure 2. Detail of  CT scan of  the thorax.
The arrow indicates the pleural empyema
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Differential diagnosis and investigations
The findings on physical examination and chest x-ray 
initially made us think of  a massive pleural effusion. After 
confirmation of  an empyema by pleuroscentesis, we 
considered the following differential diagnosis: insufficiently 
treated bacterial empyema due to Streptococcus pneumoniae, 
Staphylococcus aureus, gram-negative rods or anaerobic
micro-organisms1 iatrogenic bacterial empyema introduced 
by repeated pleuroscentesis (caused by S. aureus) and drug-
resistant pleural tuberculosis. However the trachea deviation 
to the right and the reduced right lung volume were not 
consistent with right sided pleural effusion alone and the CT 
scan provided insight into the true nature of  the abnormalities, 
namely a fluid collection AND diffuse consolidation with 
bronchiectasis or cavities in the right lung. We now favored 
diagnoses of  drug-resistant tuberculosis, bacterial infection 
in a bronchiectatic lung, uncommon bacterial lung infections 
associated with HIV infection such as Nocardiosis and 
Rhodococcosis, and super-infection of  pre-existent structural 
lung abnormalities with an Aspergillus species.
Malignancies, such as Kaposi’s sarcoma, primary serous 
lymphoma, mesothelioma and lung cancer seemed unlikely 
due to the appearance on the CT scan. The pleural fluid 
finding of  an abundance of  lymphocytes was suggestive of  
tuberculosis or partially treated bacterial infections.
The additional investigations we then ordered were: sputum 
and pleural pus for gram and Ziehl-Neelsen stains, as well 
as bacterial and mycobacterial cultures; blood culture; 
bronchoscopy (to allow visualization of  possible bronchial 
tree abnormalities such as Karposi’s sarcoma) and broncho-
alveolar lavage for microscopy and culture. We deferred 
pleural biopsy for histological examination.
Subsequently the culture of  the pleural pus grew Rhodococcus 
equi, sensitive to tetracycline and ceftriaxone and resistant 
to ciprofloxacin, chloramphenicol, penicillin, cotrimoxazole 
and erythromycin. The patient was treated with ceftriaxone 
intravenously for two weeks and doxycycline for two 
months, with good response. The empyema was drained 
using an intercostal chest drain for 7 days. When seen 
two months after discharge from hospital he had stopped 
producing sputum and the shortness of  breath had improved 
remarkably. Radiological changes in the right hemithorax 
were still extensively present.
Discussion
This is the first case of  Rhodococcus equi infection described 
in Malawi. R. equi is an aerobic, intracellular, gram-positive 
coccobacillus, with a worldwide distribution that causes 
infections in grazing animals, such as horses and foals (hence 
the name equi). Humans acquire the infection by inhalation 
or ingestion of  contaminated soil or direct inoculation due 
to trauma. It predominantly causes disease in immuno-
compromised patients, in particular those with advanced 
HIV infection2.
The most common manifestation is a slowly progressive 
necrotizing pneumonia, with symptoms similar to 
tuberculosis. Complications such as abscess, empyema,
hemoptysis, and pneumothorax can occur. Multiple nodular 
infiltrates with predilection for the upper lobes, cavitary 
pulmonary lesions and lung consolidation can be seen on
chest X-ray3. As was clearly shown in our patient, CT 
scanning of  the thorax is more sensitive to detect nodules 
and cavities than a plain radiograph. Extra-pulmonary 
manifestations include brain abscess, lymphadenitis, 
peritonitis, osteomyelitis, septic arthritis, and fever of  
unknown origin. The characteristic histological feature is 
a necrotizing granulomatous inflammation dominated by 
macrophages containing large numbers of  coccobacilli.The 
optimal drug regimen and duration of  treatment of  this 
severe infection have not been established. Because drug 
resistance may occur during therapy, it has been suggested 
that two active antibiotics are used, which should have good 
intracellular penetration. The recommended choices are 
imipenem, aminoglycosides, erythromycin or azithromycin, 
vancomycin, rifampin, and levofloxacin. However, drug 
sensitivity patterns from the isolated organism should be 
obtained. Unfortunately we were not able to use combination 
therapy due to limited antibiotic availability. Eradiation of  
R equi is challenging and requires long-term treatment, 
two months is advised for pulmonary disease3. In HIV co-
infection, antiretroviral therapy may be beneficial to cure 
R. equi infection. The high mortality rate of  around 25% 
associated with R equi infections is due to several factors: 
missed and late diagnosis, inappropriate antibiotic therapy, 
and coexistent opportunistic infections4.
This case highlights the need for continued clinical vigilance 
after a diagnosis of  smear negative pulmonary- or pleural 
tuberculosis in HIV-infected persons. If  the response to TB 
treatment does not follow the expected course, vigorous 
diagnostic efforts should be made and a full microbiological 
work-up should be pursued. A microbiological diagnosis and 
sensitivity pattern are particularly important when long-term 
antibiotic treatment is indicated.
Communication with microbiology staff  was essential in the 
diagnostic process of  our case. R. equi could have easily been 
discarded as a cotaminant because of  the morphological 
similarity it has with diphtheroid bacteria on the culture 
medium2, but knowledge of  the clinical context aided the 
correct identification in the laboratory.
Conclusion
Rhodococcus equi pneumonia is an uncommon but not 
unexpected finding in patients with HIV. It has to be 
considered in patients with a presentation of  smear-negative 
pulmonary tuberculosis and/or pleural effusion. A high index 
of  suspicion facilitates the correct laboratory identification 
of  the microorganism, which is essential for the treatment 
success of  this severe condition.
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